Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Provision of Breyanzi CAR POS T-Cells

The Clatterbridge Cancer Centre NHS Foundation Trust

This public procurement record has 1 release in its history.

Award

29 Jun 2026 at 09:38

UK5 - Transparency Notice
Summary of the contracting process

The Clatterbridge Cancer Centre NHS Foundation Trust is procuring Breyanzi CAR T-cells, a specialist pharmaceutical product used in cancer treatment. The products are to be supplied directly to the Trust, with the requirement commissioned through NHS England. Delivery is in the United Kingdom, for the Trust’s service in Bebington, Wirral. This is a goods requirement rather than a service or construction project. The selected supplier is Bristol-Myers Squibb Pharmaceuticals Limited, a pharmaceutical company. The requirement concerns a named CAR T-cell therapy, so it is relevant primarily to manufacturers, authorised pharmaceutical suppliers and organisations able to provide this product directly within NHS commissioning arrangements.

The procurement is complete and was awarded through a direct award, with Bristol-Myers Squibb Pharmaceuticals Limited selected as the supplier. The stated rationale is that NHS England commissioned the requirement and there is a single supplier for the service, supported by technical reasons. The award value is £140,250 gross, including the stated amount, in GBP. The award covers one lot and is recorded as pending, with a scheduled signature date of 1 July 2026. The contract period runs from 1 July 2026 to 2 July 2026. The award is for pharmaceutical products and is above the relevant threshold. No competitive evaluation basis is described because the route was a single-supplier direct award.

This award demonstrates demand from an NHS cancer provider for direct supply of a named CAR T-cell therapy through NHS England commissioning. A credible competitor for a future requirement would need access to the relevant advanced pharmaceutical product, the legal and operational ability to supply it directly, and established arrangements for working with NHS commissioners and specialist cancer services. The single-supplier rationale indicates that product exclusivity or technical capability is decisive, rather than general pharmaceutical distribution alone. Suppliers would therefore need strong manufacturer or authorised-distributor status, reliable short-window fulfilment to a UK cancer centre, and the governance, cold-chain and clinical supply controls appropriate to advanced cell and gene therapies.

How relevant is this notice?

Notice Information

Notice Title

Provision of Breyanzi CAR POS T-Cells

Notice Description

Purchase of Breyanzi CAR POS T-Cells, products to be supplied direct. Commissioned via NHS England.

Procurement Information

Commissioned by NHS England and single supplier only for this service.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06bebe
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/060589-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK5 - Transparency Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£140,250 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
29 Jun 20262 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
1 Jul 2026 - 2 Jul 2026 30 days
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Clatterbridge Cancer Centre NHS Foundation Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BEBINGTON, WIRRAL
Postcode
CH63 4JY
Postcode Area
Chester
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD74 Wirral
Delivery Location
Not specified
Local Authority
Wirral
Electoral Ward
Clatterbridge
Westminster Constituency
Wirral West

Supplier Information

Number of Suppliers
1
Supplier Name

Bristol Myers Squibb

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...